JP2017538767A5 - - Google Patents

Download PDF

Info

Publication number
JP2017538767A5
JP2017538767A5 JP2017533378A JP2017533378A JP2017538767A5 JP 2017538767 A5 JP2017538767 A5 JP 2017538767A5 JP 2017533378 A JP2017533378 A JP 2017533378A JP 2017533378 A JP2017533378 A JP 2017533378A JP 2017538767 A5 JP2017538767 A5 JP 2017538767A5
Authority
JP
Japan
Prior art keywords
use according
isoxazoline compound
formula
mammal
isoxazoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017533378A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017538767A (ja
JP6706262B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/080744 external-priority patent/WO2016102437A1/en
Publication of JP2017538767A publication Critical patent/JP2017538767A/ja
Publication of JP2017538767A5 publication Critical patent/JP2017538767A5/ja
Application granted granted Critical
Publication of JP6706262B2 publication Critical patent/JP6706262B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017533378A 2014-12-22 2015-12-21 毛包虫症治療のためのイソオキサゾリン化合物の使用 Active JP6706262B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14199562 2014-12-22
EP14199562.1 2014-12-22
PCT/EP2015/080744 WO2016102437A1 (en) 2014-12-22 2015-12-21 Use of isoxazoline compounds for treating demodicosis

Publications (3)

Publication Number Publication Date
JP2017538767A JP2017538767A (ja) 2017-12-28
JP2017538767A5 true JP2017538767A5 (enExample) 2019-01-24
JP6706262B2 JP6706262B2 (ja) 2020-06-03

Family

ID=52146273

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017533378A Active JP6706262B2 (ja) 2014-12-22 2015-12-21 毛包虫症治療のためのイソオキサゾリン化合物の使用

Country Status (14)

Country Link
US (3) US20170348286A1 (enExample)
EP (3) EP4008329B1 (enExample)
JP (1) JP6706262B2 (enExample)
CN (2) CN114681453A (enExample)
AU (3) AU2015371175B2 (enExample)
BR (1) BR112017013286A2 (enExample)
CA (1) CA2971296A1 (enExample)
DK (2) DK4008329T3 (enExample)
ES (2) ES3018234T3 (enExample)
FI (2) FI4008329T3 (enExample)
PL (2) PL3236960T3 (enExample)
PT (2) PT4008329T (enExample)
RU (1) RU2709198C2 (enExample)
WO (1) WO2016102437A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170232024A1 (en) 2014-08-04 2017-08-17 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
CN114681453A (zh) 2014-12-22 2022-07-01 英特维特国际股份有限公司 异噁唑啉化合物用于治疗蠕形螨病的用途
WO2018039508A1 (en) * 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
CN107501199A (zh) * 2017-08-16 2017-12-22 南京农业大学 氟雷拉纳单体化合物的提取和纯化方法
CN119174758A (zh) * 2017-12-15 2024-12-24 塔苏斯制药有限公司 用于治疗睑炎的异恶唑啉驱虫剂制剂和方法
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
US11880349B2 (en) 2019-04-30 2024-01-23 Salesforce, Inc. System or method to query or search a metadata driven distributed ledger or blockchain
WO2021127188A1 (en) 2019-12-18 2021-06-24 Elanco Tiergesundheit Ag Isoxazoline derivatives as pesticides
EP4185585A1 (en) 2020-07-24 2023-05-31 Elanco Us Inc. Process for making an isoxazoline compound and intermediate thereof
CN115785017B (zh) * 2022-12-06 2023-12-08 海利尔药业集团股份有限公司 一种取代的苯酰胺异噁唑啉衍生物或其作为农药可接受的盐、组合物及其用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2067863C1 (ru) * 1994-05-25 1996-10-20 Казанский государственный технологический университет Акарицидный состав для лечения чесотки домашних животных
WO2005085216A1 (ja) 2004-03-05 2005-09-15 Nissan Chemical Industries, Ltd. イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤
DE102004053964A1 (de) * 2004-11-09 2006-05-11 Bayer Healthcare Ag Mittel gegen Demodikose
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
EP2957284B1 (en) 2007-06-27 2018-01-17 E. I. du Pont de Nemours and Company Animal pest control method
TWI556741B (zh) 2007-08-17 2016-11-11 英特威特國際股份有限公司 異唑啉組成物及其作為抗寄生蟲藥上的應用
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
ES2442342T3 (es) 2008-12-18 2014-02-11 Novartis Ag Derivados de las isoxazolinas y su uso como pesticida
US8383659B2 (en) * 2008-12-19 2013-02-26 Novartis Ag Isoxazoline derivatives as pesticides
PL2658541T3 (pl) 2010-12-27 2022-04-04 Intervet International B.V. Preparat izoksazoliny do stosowania miejscowego zawierający glikofurol
DK2658542T4 (da) 2010-12-27 2025-08-25 Intervet Int Bv Topisk lokaliseret isoxazolinformulering
JP5806743B2 (ja) * 2011-03-10 2015-11-10 ゾエティス・エルエルシー 抗寄生虫薬としてのスピロ環式イソオキサゾリン誘導体
CN106474120B (zh) 2011-09-12 2020-07-28 勃林格殷格翰动物保健美国公司 包含异噁唑啉活性剂的杀寄生物组合物,其方法和用途
FI128926B (en) * 2012-02-06 2021-03-15 Merial Ltd Parasiticidal oral veterinary composition compositions comprising a systemically active agent for the treatment and / or prevention of a parasitic infection or infection in an animal
BR112014024833B1 (pt) 2012-04-04 2022-10-04 Intervet International B.V. Produto farmacêutico veterinário mastigável macio, processo para sua fabricação e seu uso, bem como uso de pamoato de sódio
WO2014090918A1 (en) * 2012-12-13 2014-06-19 Novartis Ag Process for the enantiomeric enrichment of diaryloxazoline derivatives
JP6581586B2 (ja) * 2013-12-20 2019-09-25 インターベット インターナショナル ベー. フェー. イソオキサゾリン組成物および動物における寄生虫侵襲の予防または処置におけるその使用
CN114681453A (zh) 2014-12-22 2022-07-01 英特维特国际股份有限公司 异噁唑啉化合物用于治疗蠕形螨病的用途

Similar Documents

Publication Publication Date Title
JP2017538767A5 (enExample)
JP2015512435A5 (enExample)
JP2016540809A5 (enExample)
RU2017126029A (ru) Применение изоксазолиновых соединений для лечения демодекоза
JP2016539960A5 (enExample)
JP2013544846A5 (enExample)
JP2013510124A5 (enExample)
JP2013537203A5 (enExample)
JP2018517746A5 (enExample)
JP2017504635A5 (enExample)
JP2010524932A5 (enExample)
JP2016506369A5 (enExample)
JP2012144574A5 (enExample)
JP2016540028A5 (enExample)
JP2016506962A5 (enExample)
JP2015504081A5 (enExample)
JP2014504586A5 (enExample)
JP2013545785A5 (enExample)
JP2016506960A5 (enExample)
JP2016516043A5 (enExample)
JP2013032389A5 (enExample)
JP2017508782A5 (enExample)
JP2014521688A5 (enExample)
JP2017537949A5 (enExample)
JP2016505614A5 (enExample)